News Banner

News Update

  • RML Quality Assurance Program (RML-QAP)

    We have completed our Seven successful years of Running “Quality Assurance Program” under the banner of RML Research Foundation Society with more than 400(Four hundred Participants) from across India in the year 2018. Now we can proudly share with you that we are first few labs in the country and probably first private QAP Program provider, which has undertaken the accreditation of Proficiency Testing Program. Following ISO-17043 accreditation the RML PT Program will become of international standard for all the below mentioned fields: .

    • Biochemistry

    • Immunology

    • Hematology

    • Microbiology & Serology

    • Histopathology & Cytopathology

    • Urine Analysis (New)

    • Haemoglobin (HbA1C) (New)

    “Our goal has always been to deliver the best and we are making continual efforts to improve & update our services.”

    We have started accepting fresh enrollment for RML QAP for year 2018. Get your lab enrolled before 31st Jan, 2018 , as will start dispatching first cycle sample from 10th February, 2018 onwards.

    For more details you can mail us on or can call us on 0522-4034100 Extn. 435

  • RML introduces invitro World Class Phadia Allergy Testing

    Padia allergy system for Inhalation,Contact and ingest-ants allergens
  • RML introduces MTHFR Real time PCR

    An MTHFR is a problem associated with poor methylation and enzyme production , it affect every person differently.
  • RML introduces Beta-Thalassimia by PCR

    It is a blood disorder that reduces the production of haemoglobin.
  • RML introduces MRSA by Gene Expert

    It is a form of bacterial infection that is resistant to numerous antibiotics
  • RML Introduces C.difficile by Gene Expert

    It is a bacteria that can cause symptoms ranging from diarrhoea to life threatening inflammation of colon.
  • RML Introduces Carba-R by Gene Xpert

    Detection of patient carrying Carbapenemase producing micro organisms with differentiation among the five major families causing resistance genes with result in less than 1 hour.
  • RML introduces Dengue by PCR

    Advanced diagnosis for Dengue.
  • RML introduces Chikungunya by PCR

    Advance diagnosis for Chikungunya
  • RML introduces APO-E by PCR

    Apolipoprotein E is a class of protein involved in the metabolism of fats in the body it is important in Alzheimer disease and cardio vascular disease
  • RML introduces EGFR by PCR

    EGFR is a protein coding gene . diseases associated with EGFR include brain ependymoma and esophageal basaloid squamous cell carcinoma.
  • RML Introduces Aquaporin 4 test for the detection of Neuromyelitis optica (NMO).

    Neuromyelitis optica (NMO) is a demyelinating disease of the central nervous system (CNS) of putative autoimmune aetiology. Early discrimination between multiple sclerosis (MS) and NMO is important, as optimum treatment for both diseases may differ considerably. Recently, using indirect immunofluorescence analysis, a new serum autoantibody (NMO-IgG) has been detected in NMO patients. The binding sites of this autoantibody were reported to colocalize with aquaporin 4 (AQP4) water channels. Thus we hypothesized that AQP4 antibodies in fact characterize NMO patients.

  • RML Introduces Anti Acetylcholine Receptor IgG Test for the detection of Myasthenia gravis.

    Myasthenia gravis (MG) is a condition in which severe weakness of critical muscles can be fatal. In myasthenia gravis autoantibodies against the acetylcholine receptor (ACHRAB) in the motor end plate cause failure of the neuromuscular transmission. Life -saving treatment is now available at RML.

  • RML Introduces Immunoglobulin Subclass Serum IgG4 & IgG4 IHC Test

    IgG subclass 4-related disease is a recently recognized syndrome of unknown etiology most often occurring in middle -aged and older men.Several organ systems can be involved and encompasses many previous and newly described diseases such as type 1 autoimmune pancreatitis;Mikulicz disease and sclerosing sialadenitis; inflammatory orbital psuedotumor; chronic sclerosing aortitis; Riedel thyroiditis , a subset of Hashimoto thyroiditis; IgG4-related interstital pneumonitis; and IgG4-related tubulointerstital nephritis.Each of these entities is characterized by tumorlike swelling of the involved organs with infiltrative,predominately IgG4-positive, plasma cells with accompanying " storiform" fibrosis. In addition,elevated serum concentrations of IgG4 are found in 60% to 70% of patients diagnosed with IgG4-related disease

  • RML Intoduce HAINS Molecular test for XDR Tuberculosis

    (2nd Line ATT drug Mutation Testing for -Fluoroquinolones, Aminoglycosides/ Cyclic peptides and Ethambutol Test give very rapid results within 2 days. XDR TB: eXtremely Drug Resistance TB
  • RML Introduces JAK-2 Mutation studies Real Time PCR testing for BCR ABL negative

    The JAK2 mutation test may be used, along with other tests such as erythropoietin, to help diagnose bone marrow disorders that lead to overproduction of blood cells. These conditions are known as myeloproliferative neoplasms (MPNs).

  • RML Introduces Serum Leptin Test

    Leptin is an adipocyte-derived hormone that is essential for normal body weight regulation .Leptin production is under neuroendocrine control so that serum concentrations vary directly vary directly with the amount of triglycerides stored in adipose tissue depots.

  • RML Introduces Respiratory Syncitial Virus(RSV) Test

    RSV is the commonest cause of Viral Respiratory tract infection (RTI) in Children below 1 year of age. Its is associated with Influenza like illness producing both upper and lower RTI. RSV is a major cause of Bronchiolitis and Pneumonia in Infants and Children.
  • RML Introduces GENE XPERT Quantitative BCR-ABL Molecular Test

    RML Introduces, Advanced Molecular Test for Diagnosis & Monitoring Treatment of CML with Same day reporting of results of Quantitative BCR-ABL Molecular Test . The results are reported as Ratio of BCR-ABL Fusion Gene and the ABL housekeeping gene as per International Standard of reporting.